Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lichtenwalner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Analytical Toxicology|December 17, 1997
A fatality involving zolpidemM Lichtenwalner, R Tully
The Journal of Clinical Investigation|October 1, 1987
Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infantsB Suh, S J Wadsworth, D M Lichtenwalner
Journal of Analytical Toxicology|March 1, 1988
Quantitative determination of phenelzine in human fluids by gas chromatography with nitrogen specific detectionM Lichtenwalner, M McMullin, D Hardy, et al.
The Journal of Clinical Investigation|May 1, 1983
Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremiaD M Lichtenwalner, B Suh, M R Lichtenwalner
Antimicrobial Agents and Chemotherapy|August 1, 1979
New rapid assay for nafcillin in serum by spectrofluorometryD M Lichtenwalner, B Suh, B Lorber, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1979
Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometryD M Lichtenwalner, B Suh, B Lorber, et al.
Biochemical Pharmacology|November 1, 1982
Correction of drug binding defects in uremia in vitro by anion exchange resin treatmentD M Lichtenwalner, B Suh, B Lorber, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1981
Partial purification and characterization of the drug-binding-defect inducer in uremiaD M Lichtenwalner, B Suh, B Lorber, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Analytical Toxicology|December 17, 1997
A fatality involving zolpidemM Lichtenwalner, R Tully
The Journal of Clinical Investigation|October 1, 1987
Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infantsB Suh, S J Wadsworth, D M Lichtenwalner
Journal of Analytical Toxicology|March 1, 1988
Quantitative determination of phenelzine in human fluids by gas chromatography with nitrogen specific detectionM Lichtenwalner, M McMullin, D Hardy, et al.
The Journal of Clinical Investigation|May 1, 1983
Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremiaD M Lichtenwalner, B Suh, M R Lichtenwalner
Antimicrobial Agents and Chemotherapy|August 1, 1979
New rapid assay for nafcillin in serum by spectrofluorometryD M Lichtenwalner, B Suh, B Lorber, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1979
Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometryD M Lichtenwalner, B Suh, B Lorber, et al.
Biochemical Pharmacology|November 1, 1982
Correction of drug binding defects in uremia in vitro by anion exchange resin treatmentD M Lichtenwalner, B Suh, B Lorber, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1981
Partial purification and characterization of the drug-binding-defect inducer in uremiaD M Lichtenwalner, B Suh, B Lorber, et al.
Pageof 1